Olmesan Plus
( Olmesartan Medoxomil and Hydrochlorothiazide )
It is a combination of an angiotensin II receptor antagonist (AT1 subtype), olmesartan medoxomil, and a thiazide diuretic, hydrochlorothiazide (HCTZ). Olmesartan medoxomil, a prodrug, is hydrolyzed to olmesartan during absorption from the gastrointestinal tract.
- Most powerful AT1 receptor blocker with highest degree of BP reduction
- Truly once daily dosing with powerful efficacy even during last 4 hours of 24-hour dosing period
- Prompt BP reduction compared to losartan even after 2 weeks of therapy
- Provides powerful antiatherosclerotic effect in addition to its strong antihypertensive effect
